177 related articles for article (PubMed ID: 9059994)
1. Tamoxifen enhances interferon-regulated gene expression in breast cancer cells.
Lindner DJ; Kolla V; Kalvakolanu DV; Borden EC
Mol Cell Biochem; 1997 Feb; 167(1-2):169-77. PubMed ID: 9059994
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor effects of a combination of interferon and tamoxifen on estrogen receptor-positive and receptor-negative human tumor cell lines in vivo and in vitro.
Lindner DJ; Borden EC
J Interferon Cytokine Res; 1997 Nov; 17(11):681-93. PubMed ID: 9402106
[TBL] [Abstract][Full Text] [Related]
3. Human recombinant interferon-beta SER and tamoxifen: growth suppressive effects for the human breast carcinoma MCF-7 grown in the athymic mouse.
Gibson DF; Johnson DA; Goldstein D; Langan-Fahey SM; Borden EC; Jordan VC
Breast Cancer Res Treat; 1993; 25(2):141-50. PubMed ID: 8347846
[TBL] [Abstract][Full Text] [Related]
4. Interferon (IFN) beta acts downstream of IFN-gamma-induced class II transactivator messenger RNA accumulation to block major histocompatibility complex class II gene expression and requires the 48-kD DNA-binding protein, ISGF3-gamma.
Lu HT; Riley JL; Babcock GT; Huston M; Stark GR; Boss JM; Ransohoff RM
J Exp Med; 1995 Nov; 182(5):1517-25. PubMed ID: 7595221
[TBL] [Abstract][Full Text] [Related]
5. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
[TBL] [Abstract][Full Text] [Related]
7. Effects of type I and II interferons on cultured human breast cells: interaction with estrogen receptors and with tamoxifen.
Goldstein D; Bushmeyer SM; Witt PL; Jordan VC; Borden EC
Cancer Res; 1989 May; 49(10):2698-702. PubMed ID: 2469536
[TBL] [Abstract][Full Text] [Related]
8. Resistance to interferons in melanoma cells does not correlate with the expression or activation of signal transducer and activator of transcription 1 (Stat1).
Chawla-Sarkar M; Leaman DW; Jacobs BS; Tuthill RJ; Chatterjee-Kishore M; Stark GR; Borden EC
J Interferon Cytokine Res; 2002 May; 22(5):603-13. PubMed ID: 12060499
[TBL] [Abstract][Full Text] [Related]
9. IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7.
Sancéau J; Hiscott J; Delattre O; Wietzerbin J
Oncogene; 2000 Jul; 19(30):3372-83. PubMed ID: 10918594
[TBL] [Abstract][Full Text] [Related]
10. Regulation of interferon-alpha/beta-stimulated gene expression through the gamma-activated transcriptional element.
Weihua X; Ling W; Kalvakolanu DV
Antiviral Res; 1999 Jan; 40(3):145-53. PubMed ID: 10027649
[TBL] [Abstract][Full Text] [Related]
11. Impaired alpha-interferon signaling in transitional cell carcinoma: lack of p48 expression in 5637 cells.
Matin SF; Rackley RR; Sadhukhan PC; Kim MS; Novick AC; Bandyopadhyay SK
Cancer Res; 2001 Mar; 61(5):2261-6. PubMed ID: 11280796
[TBL] [Abstract][Full Text] [Related]
12. Induction of growth suppression and modification of gene expression in multi-drug-resistant human glioblastoma multiforme cells by recombinant human fibroblast and immune interferon.
Moulton TA; Jiang H; Guarini L; Fetell MR; Fisher PB
Int J Cancer; 1992 May; 51(3):373-8. PubMed ID: 1317362
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of cytotoxicity using combinations of interferons (types I and II), tumor necrosis factor-alpha, and tamoxifen in MCF-7 cells.
Tiwari RK; Wong GY; Liu J; Miller D; Osborne MP
Cancer Lett; 1991 Dec; 61(1):45-52. PubMed ID: 1764697
[TBL] [Abstract][Full Text] [Related]
14. IFN-gamma priming up-regulates IFN-stimulated gene factor 3 (ISGF3) components, augmenting responsiveness of IFN-resistant melanoma cells to type I IFNs.
Wong LH; Hatzinisiriou I; Devenish RJ; Ralph SJ
J Immunol; 1998 Jun; 160(11):5475-84. PubMed ID: 9605150
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen enhances myoepithelial cell suppression of human breast carcinoma progression in vitro by two different effector mechanisms.
Shao ZM; Radziszewski WJ; Barsky SH
Cancer Lett; 2000 Sep; 157(2):133-44. PubMed ID: 10936673
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional induction of the p69 isoform of 2',5'-oligoadenylate synthetase by interferon-beta and interferon-gamma involves three regulatory elements and interferon-stimulated gene factor 3.
Floyd-Smith G; Wang Q; Sen GC
Exp Cell Res; 1999 Jan; 246(1):138-47. PubMed ID: 9882523
[TBL] [Abstract][Full Text] [Related]
17. Tamoxifen regulates human telomerase reverse transcriptase (hTERT) gene expression differently in breast and endometrial cancer cells.
Wang Z; Kyo S; Maida Y; Takakura M; Tanaka M; Yatabe N; Kanaya T; Nakamura M; Koike K; Hisamoto K; Ohmichi M; Inoue M
Oncogene; 2002 May; 21(22):3517-24. PubMed ID: 12032853
[TBL] [Abstract][Full Text] [Related]
18. The effect of alpha-, beta- and gamma-interferon on the growth of breast cancer cell lines.
Coradini D; Biffi A; Pirronello E; Di Fronzo G
Anticancer Res; 1994; 14(5A):1779-84. PubMed ID: 7531412
[TBL] [Abstract][Full Text] [Related]
19. Effects of tamoxifen and interferon-beta or the combination on tumor-induced angiogenesis.
Lindner DJ; Borden EC
Int J Cancer; 1997 May; 71(3):456-61. PubMed ID: 9139884
[TBL] [Abstract][Full Text] [Related]
20. Induction of expression of interferon-stimulated gene factor-3 (ISGF-3) proteins by interferons.
Kumar R; Korutla L
Exp Cell Res; 1995 Jan; 216(1):143-8. PubMed ID: 7529187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
